|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||
|
||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sB08AF8A8-3BB5-11EF-B7A8-F1EB84CE164B&I=39IZM&T=&OP=Display&O=html&O1=12909034&O2=2670000000385709&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DThe%2520Society%2520for%2520Immunotherapy%2520of%2520Cancer%2520statement%2520on%2520best%2520practices%2520for%2520multiplex%2520immunohistochemistry%2520%2528IHC%2529%2520and%2520immunofluorescence%2520%2528IF%2529%2520staining%2520and%2520validation%26rft.au%3DAkturk%252C%2520Guray%26rft.au%3DAngelo%252C%2520Michael%26rft.au%3DEngle%252C%2520Elizabeth%2520L%26rft.au%3DTaube%252C%2520Janis%2520M%26rft.date%3D2020-05-01%26rft.eissn%3D2051-1426%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Dproceeding%26rft.issue%3D1%26rft.title%3DJournal%2520for%2520immunotherapy%2520of%2520cancer%26rft.volume%3D8%26rft_id%3Dinfo%253Adoi%252F10.1136%252Fjitc-2019-000155%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,4-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,5-GFMER_FREE_MEDICAL_JOURNALS-getFullTxt-object,6-PROQUEST_CENTRAL-getFullTxt-object,7-ROAD_DIRECTORY_OF_OPEN_ACCESS_SCHOLARLY_RESOURCES-getFullTxt-object,8-COBIB_SI_LCL-getHolding-object,9-DOI-getDOI-object,10-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,11-REFWORKS_EXPORT_TOOL-getReference-object,12-SHERPA_RoMEO_LCL-getWebService-object,13-GOOGLE_SCHOLAR_FREE-getWebSearch-object,14-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.228018&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12909034-sB08AF8A8-3BB5-11EF-B7A8-F1EB84CE164B" timestamp="2024-07-06T18:35:03Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:2670000000385709</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation</jnl:atitle>
<jnl:jtitle>Journal for Immunotherapy of Cancer</jnl:jtitle>
<jnl:date>2020-05-15</jnl:date>
<jnl:spage>e000155</jnl:spage>
<jnl:volume>8</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>proceeding</jnl:genre>
<jnl:eissn>2051-1426</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:9683e54fc83e1080a3d8d5ccd3a0b106ca6076cc</ctx:identifier>
<ctx:identifier>urn:UUID:sB08AF8A8-3BB5-11EF-B7A8-F1EB84CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)